TRU - Truscreen Additional Placement
Truscreen Group Limited (NZX/ASX:TRU) is pleased to advise that further to the announcement of 4 March 2024 “Truscreen Raises Initial NZ$500,000 in Share Placement”, the Company has received a further firm commitment from an investor 
© 2024 sharechat.co.nz Wed, 13 Mar 3:45pm TRU - CEO Resignation and Interim CEO Appointment
Truscreen Group Limited (NZX/ASX:TRU) announces that for personal reasons, CEO, Dr. Beata Edling has resigned effective immediately and will assist in the transition to an interim CEO in the coming weeks.
© 2024 sharechat.co.nz Fri, 23 Feb 11:45am TRU - Approval in Mexico to Enter Public Health Sector
TruScreen receives Approval in Mexico to enter public health sector
© 2024 sharechat.co.nz Wed, 7 Feb 12:05am TruScreen Awarded Zimbabwe Tender
Truscreen Group Limited (NZX/ASX:TRU) is pleased to confirm the receipt of a further purchase order from Zimbabwe for SUS (single use sensor) with a gross sales value of approximately NZ$300,000
© 2024 sharechat.co.nz Mon, 6 Nov 12:05am TruScreen - Commercial Breakthrough in Saudi Arabia
TruScreen Group Limited (NZX/ASX:TRU) is pleased to report that the Dr Sulaiman Al-Habib Medical Group, has installed the first tranche of four TruScreen devices for commercial use, for the screening of cervical cancer in Saudi Arabia
© 2024 sharechat.co.nz Mon, 18 Sep 11:45am TRU - Strong Sales Growth in Q1 FY2024 (April to June 2023)
Truscreen Group Limited (NZX/ASX:TRU) is pleased to report a 100% growth in sales over the same quarter year on year and a 73% growth in sales of Single Use Sensor (SUS) for the same period
© 2024 sharechat.co.nz Tue, 15 Aug 12:20am TruScreen Recognised in Authoritative China Blue Paper
TruScreen Recognised in Authoritative China Blue Paper – “Cervical Cancer Three Stage Standardised Prevent and Treat”
© 2024 sharechat.co.nz Mon, 8 May 1:45pm  TRU - Commercial Update
Cervical cancer screening technology company, TruScreen Group Limited (NZX/ASX: TRU) (‘TruScreen’ or ‘the Company), is pleased to provide this commercial update
© 2024 sharechat.co.nz Wed, 15 Feb 11:02am TruScreen Half Year Results
Cervical cancer screening technology company, TruScreen Group Limited (NZX/ASX: TRU) (‘TruScreen’ or ‘the Company), is pleased to provide its unaudited financial results for the six months to 30 September 2022 (1H FY23)
© 2024 sharechat.co.nz Tue, 29 Nov 11:07am  |
|
 |
 
Truscreen Raises Initial NZ$500,000 in Share Placement
Truscreen Group Limited (NZX/ASX:TRU) is pleased to advise that further to the announcement of 12 February 2024 “Truscreen to lodge a pro rata renounceable rights issue”
© 2024 sharechat.co.nz Mon, 4 Mar 1:25pm Reimbursement Approval from Health Insurers in Saudi Arabia
TruScreen Secures Reimbursement Approval from Health Insurers in Saudi Arabia
© 2024 sharechat.co.nz Mon, 12 Feb 3:25pm  TuScreen Included on Vietnamese MOH Approved Technical List
TruScreen Group Limited (NZX/ASX:TRU) is pleased to advise that it has been included in the Vietnamese Ministry Of Health (MOH) approved Technical List. This significant milestone enables TruScreen to be used nationally from top level hospitals to communi
© 2024 sharechat.co.nz Wed, 13 Dec 1:11pm TRU - Strong Sales Growth in China in Improved Half Year Results
Truscreen Group Limited (NZX/ASX:TRU) is pleased to report a 33% growth in H1 FY24 product sales and a 28% growth in sales of Single Use Disposable Sensors (SUS) sales against the same period last year
© 2024 sharechat.co.nz Thu, 12 Oct 11:13am  Truscreen Opto-electrical Technology Recognised
TruScreen opto-electrical technology recognized in China Cervical Cancer Screening Guideline by top national expert organisation
© 2024 sharechat.co.nz Wed, 2 Aug 3:45pm TRU - Growing Recognition for TruScreen
Truscreen Group Limited (NZX/ASX:TRU) is pleased with the growing acknowledgement and acceptance of the TruScreen real time cervical cancer screening device. TruScreen is NMPA (China, formerly CFDA) and CE mark certified as primary cervical cancer screeni
© 2024 sharechat.co.nz Mon, 1 May 1:47pm TruScreen Half Year Results
Cervical cancer screening technology company, TruScreen Group Limited (NZX/ASX: TRU) (‘TruScreen’ or ‘the Company), is pleased to provide its unaudited financial results for the six months to 30 September 2022 (1H FY23)
© 2024 sharechat.co.nz Tue, 6 Dec 11:17am
|
|
